Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published 14 July 2009
Cite this as: BMJ Case Reports 2009 [doi:10.1136/bcr.02.2009.1635]
Copyright © 2009 by the BMJ Publishing Group Ltd.

Unexpected outcome (positive or negative) including adverse drug reactions

Fatal pulmonary embolism of polyvinyl alcohol particles following therapeutic embolisation of a peripheral arteriovenous malformation

Serosha Mandika Wijeyaratne1, Ranjuka Arushana Ubayasiri2, Charitha Weerasinghe2

1 University of Colombo, Department of Surgery, Kynsey Road, Colombo, 7, Sri Lanka
2 Colombo National Hospital, Surgery, Kynsey Road, Colombo, 7, Sri Lanka

Correspondence to:
Serosha Mandika Wijeyaratne, mandika59{at}hotmail.com

SUMMARY

Embolotherapy of arteriovenous malformations (AVM) is not without risk. A 28-year-old woman underwent transcatheter selective embolisation of an AVM in the cheek using polyvinyl alcohol (PVA) microparticles. She became hypoxic and hypotensive post procedure, and had repeated cardiorespiratory arrests despite aggressive support. Resistant hypoxia with gross right heart dilatation on echocardiography suggested extensive pulmonary embolism. She died 24 h later. A postmortem confirmed widespread thrombosis and PVA particles in the pulmonary microvasculature identical to that in the treated AVM. This is the first reported death from PVA particle pulmonary embolism following therapeutic embolisation of a peripheral AVM.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) -   become a fellow  today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts  so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog